ZNF322 and lung carcinoma: In addition, we found that deregulation of CK1δ-GSK3β-FBXW7α protein degradation system or activation of EGFR-AKT signaling axis results in prolonged ZNF322A stability and transcription activity promoting lung cancer progression 14,15.